Clinical Trial Update: Exploratory Study on the Efficacy of Zebutinib as Maintenance Therapy Following CAR-T Cell Therapy in Patients With Non-Hodgkin B-Cell Lymphoma

View source ↗

Summary

Exploratory study evaluating Zebutinib as maintenance therapy after CAR-T treatment in patients with B-cell non-Hodgkin lymphoma; recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Drugs mentioned

• Zebutinib

Snippet

Sponsor: Beijing GoBroad Hospital | Conditions: B Cell Lymphoma | Status: NOT_YET_RECRUITING